· 112 views

Dexcom G7 Direct to Apple Watch Now Available in the US

What Healthcare Providers Need to Know About Dexcom G7 Direct to Watch Feature

 

Seamless Glucose Monitoring: Dexcom G7 and Apple Watch Integration 

In a significant advancement for diabetes care technology, Dexcom, Inc. has launched direct integration of its Dexcom G7 Continuous Glucose Monitoring (CGM) System with Apple Watch in the United States, United Kingdom, and Ireland and other regions. This innovation marks Dexcom G7 as the first CGM system capable of transmitting real-time glucose readings directly to Apple Watch, enabling users to monitor their glucose levels without needing their iPhone nearby.†  

Enhanced Patient Convenience and Accessibility  

Direct to Apple Watch with Dexcom G7 offers several advantages for healthcare professionals (HCPs) and their patients. The primary benefit is the convenience and immediacy of glucose data access. Patients no longer need to check their smartphones or separate Dexcom receiver; instead, they can view their glucose levels and trend arrows discreetly and effortlessly on their wrist. The ability to leave their phone behind† during exercise, sleep, or social outings facilitates greater flexibility and freedom to those living with diabetes. 

Using Dexcom G7 and Apple Watch also provides another form of convenience in allowing patients to view all their health data all in one place.  The Apple Health app shows activity, sleep, cycle tracking, and other health data alongside glucose readings from Dexcom G7.    

Improved Adherence and Patient Engagement 

Enhanced ease of access to real-time glucose readings makes it easier for patients to adhere to glucose monitoring routines and engage with their CGM data.  Patients who interact with CGM data show improved outcomes for both metabolic and diabetes distress symptoms.1, 2 

The ability to glance at their wrist to view glucose data and trend arrows makes it easier for patients to check glucose at times when it’s inconvenient to pull out their phones, such as during meetings or at dinner. 

Timely Alerts and Clinical Decision Support 

The Dexcom Apple Watch integration enables the ability to respond promptly to glucose fluctuations.  Immediate alerts and notifications on the Apple Watch allow patients to take timely action in cases of hypoglycemia or hyperglycemia.  The ability to rapidly respond to glucose fluctuations without the need for a smartphone is particularly beneficial in scenarios where quick action is critical, such as during physical activity, traveling, or sleep.  Additionally, patients can acknowledge alerts directly from their watch, eliminating the need to open the Dexcom G7 app to acknowledge alerts. 

Connecting Apple Watch with Dexcom G7 

  • To utilize the Dexcom G7 Direct to Watch feature, users need: 
  • Dexcom G7 app version 2.1 
  • Apple Watch Series 6 or later running watchOS 10 or later 
  • iPhone running iOS 17 or later 

To setup, instruct patients to open their Dexcom G7 app and go to Connections > Direct to Watch.  Then, follow on-screen instructions to set up the integration.  For additional support, access Dexcom Direct to Watch FAQs.

Other Dexcom G7 Compatible Watches

Dexcom Direct to Watch is currently only available for patients with Apple Watch Series 6 or iPhone running iOS 17 or later. However, patients can still use standard watch mode to view glucose readings on other smartwatches as long as their smartphone maintains a Bluetooth connection with their sensor. To view Dexcom G7 compatible watches, go to dexcom.com/compatibility. 

Dexcom G7 Direct to Apple Watch Patient Resources

For more information, healthcare providers can refer patients to: 

 

References

  1. Champakanath A, Akturk HK, Alonso GT, Snell-Bergeon JK, Shah VN. Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study. Diabetes Care. 2022;45(3):750-753. doi:10.2337/dc21-2004 
  2. Crawford MA, Hicks, C, Genge P, Greenawald K, Tressler M, Cherñavvsky DR, Singh H.  677-P: Exploring the Impact of CGM on Perceived Control of Non-Intensive Insulin Treated Type 2 Diabetes - "I liked keeping my line with as few spikes as possible".  Diabetes.  2023;72:677. doi:10.2337/db23-677-P

*Smart device sold separately. To view a list of compatible devices, visit dexcom.com/compatibility. †Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 33 feet of the Dexcom G7.

MAT-4459